stockrow
Friday 6 November 2026
Export SHPH’s income statement to Excel — free account
Shuttle Pharmaceuticals Holdings, Inc.
SHPH Healthcare Drug Manufacturers Specialty & Generic
- EPS
- +90.6%
- Free cash flow
- +82.0%
Quarter to June 2026, against a year earlier
5.32
0.28
+5.56%
Follow SHPH
Alert me
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (90.05%) | (326.36%) | (791.04%) | (27,170.81%) |
+8 more TTM periods Free account |
|
| (72.47%) | (126.42%) | (180.58%) | (507.78%) | ||
ROIC |
(36.73%) | (309.75%) | (387.83%) | 0.00% | |
Return on Tangible Assets |
334.30% | 185.73% | 157.41% | (811.44%) | |
Average Days of Receivables |
— | — | — | — | |
Free Cash Flow per Share |
(6.57) | (18.76) | (34.09) | (50.13) | |
Free Cash Flow |
(6.67) | (9.44) | (9.51) | (11.20) | |
Capital Expenditures |
(0.08) | (0.07) | (0.03) | — | |
| Other line items | |||||
Cash ROIC |
(34.60%) | (212.78%) | (367.51%) | (320.99%) | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
— | (157.50) | (168.31) | (184.53) | |
Operating CF/Net income |
0.64 | 0.87 | 0.81 | 1.05 | |
Depreciation/Fixed assets |
105.33 | 60.74 | 20.35 | 2.78 | |
Capex/Depreciation |
(0.05) | (0.07) | (0.09) | 0.00 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(6.49) | (18.62) | (33.98) | (50.13) | |
Capex per Share |
(0.08) | (0.13) | (0.11) | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | — |
Columns are period end dates · fundamentals updated 26 Oct 2026